Titelia

Holdings of HealthInvest Sustainable Healthcare

Atle Fund Management AB ·57 declared positions · as of Mar 31, 2026

Original filing · Net assets 3.2B SEK · Ten largest lines: 43.9 % of the equity sleeve

Sector breakdown

  • Health care 63.3 %
  • Industrials 1.6 %
  • Materials 1.5 %
  • Unattributed 33.7 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • SEK 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 72.5 %
  • SE 7.5 %
  • GB 5.7 %
  • BE 3.8 %
  • DK 3.6 %
  • CH 2.7 %
  • IE 1.2 %
  • ES 1.1 %
  • FR 1.1 %
  • NL 0.8 %

Shares computed on the equity sleeve.

CountryLinesValueShare
US352.3B SEK72.52 %
SE9233.5M SEK7.49 %
GB1176.8M SEK5.67 %
BE2118.6M SEK3.80 %
DK3113.3M SEK3.63 %
CH283.5M SEK2.68 %
IE137.5M SEK1.20 %
ES134.5M SEK1.11 %
FR234.1M SEK1.09 %
NL125.2M SEK0.81 %

Positions

CompanySharesValueWeight
Eli Lilly & Co 29,187254.2M SEK7.98 %
Merck & Co Inc 190,516217M SEK6.81 %
AstraZeneca PLC 96,038176.8M SEK5.55 %
Thermo Fisher Scientific Inc 29,398136.8M SEK4.29 %
Johnson & Johnson 48,859113.1M SEK3.55 %
Vertex Pharmaceuticals Inc 25,010105.7M SEK3.32 %
AbbVie Inc 47,75398.3M SEK3.09 %
Stryker Corp 29,15490.7M SEK2.85 %
Intuitive Surgical Inc 20,48889.4M SEK2.81 %
CVS Health Corp 129,03487.7M SEK2.75 %
Boston Scientific Corp 140,94483.7M SEK2.63 %
Amgen Inc 24,77282.5M SEK2.59 %
Edwards Lifesciences Corp 103,23078.3M SEK2.46 %
Swedish Orphan Biovitrum AB 187,40473.5M SEK2.31 %
Gilead Sciences Inc 51,34967.8M SEK2.13 %
BEONE MEDICINES LTD 23,84767.1M SEK2.10 %
Cencora Inc 21,02062.5M SEK1.96 %
Argenx SE 8,74359.4M SEK1.86 %
UCB SA 20,93559.2M SEK1.86 %
Insmed Inc 36,41856.4M SEK1.77 %
Bridgebio Pharma Inc 78,66155.3M SEK1.74 %
Genmab A/S 20,04450.3M SEK1.58 %
Lonza Group AG 8,26449.4M SEK1.55 %
Ionis Pharmaceuticals Inc 69,34949.3M SEK1.55 %
Incyte Corp 51,31245.7M SEK1.44 %
Revolution Medicines Inc 48,64644.8M SEK1.41 %
Mirum Pharmaceuticals Inc 50,76344.4M SEK1.39 %
Camurus AB 93,14643.5M SEK1.37 %
Neurocrine Biosciences Inc 34,35342.9M SEK1.34 %
Alkermes PLC 111,89737.5M SEK1.18 %
Almirall SA 259,26234.5M SEK1.08 %
H Lundbeck A/S 587,86034.4M SEK1.08 %
Ypsomed Holding AG 10,43434.1M SEK1.07 %
IRhythm Holdings Inc 29,69233.2M SEK1.04 %
Krystal Biotech Inc 12,48730.5M SEK0.96 %
Novo Nordisk A/S 84,82228.7M SEK0.90 %
Abivax SA 24,91626.3M SEK0.82 %
Universal Health Services Inc 15,49126.3M SEK0.82 %
BoneSupport Holding AB 132,86025.9M SEK0.81 %
Celcuity Inc 23,36925.3M SEK0.79 %
Newamsterdam Pharma Co NV 83,29625.2M SEK0.79 %
Ideaya Biosciences Inc 79,25725M SEK0.78 %
Dexcom Inc 42,03725M SEK0.78 %
Tango Therapeutics Inc 119,56223.7M SEK0.74 %
Spyre Therapeutics Inc 47,48022.7M SEK0.71 %
Compass Therapeutics Inc 395,36719.8M SEK0.62 %
BioArctic AB 60,76819.4M SEK0.61 %
Devyser Diagnostics AB 242,61618.4M SEK0.58 %
Disc Medicine Inc 29,24917.7M SEK0.56 %
Sectra AB 69,54115.7M SEK0.49 %
Hansa Biopharma AB 486,40415.5M SEK0.49 %
Bicara Therapeutics Inc 77,45714.6M SEK0.46 %
Soleno Therapeutics Inc 44,56914.1M SEK0.44 %
Egetis Therapeutics AB (publ) 2,183,92812M SEK0.38 %
Pyxis Oncology Inc 771,99410.7M SEK0.33 %
BioInvent International AB 428,7359.5M SEK0.30 %
Valneva SE 254,1827.8M SEK0.25 %